Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes.
Retraction Notice to: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes.
Cell Metab. 2020 Oct 06;32(4):691
Authors: Ezzat S, Zheng L, Florez JC, Stefan N, Mayr T, Hliang MM, Jablonski K, Harden M, Stanĉáková A, Laakso M, Haring HU, Ullrich A, Asa SL
PMID: 33027678 [PubMed]
Source: Cell Metabolism - Category: Cytology Authors: Ezzat S, Zheng L, Florez JC, Stefan N, Mayr T, Hliang MM, Jablonski K, Harden M, Stanĉáková A, Laakso M, Haring HU, Ullrich A, Asa SL Tags: Cell Metab Source Type: research
More News: Cancer | Cancer & Oncology | Cytology | Diabetes | Endocrinology | Insulin | Pancreas | Pancreatic Cancer